LLY

1,077.28

-2.33%↓

JNJ

221.91

-1.45%↓

ABBV

213.42

-2.08%↓

UNH

382.1

+0.91%↑

MRK

115.62

-2.51%↓

LLY

1,077.28

-2.33%↓

JNJ

221.91

-1.45%↓

ABBV

213.42

-2.08%↓

UNH

382.1

+0.91%↑

MRK

115.62

-2.51%↓

LLY

1,077.28

-2.33%↓

JNJ

221.91

-1.45%↓

ABBV

213.42

-2.08%↓

UNH

382.1

+0.91%↑

MRK

115.62

-2.51%↓

LLY

1,077.28

-2.33%↓

JNJ

221.91

-1.45%↓

ABBV

213.42

-2.08%↓

UNH

382.1

+0.91%↑

MRK

115.62

-2.51%↓

LLY

1,077.28

-2.33%↓

JNJ

221.91

-1.45%↓

ABBV

213.42

-2.08%↓

UNH

382.1

+0.91%↑

MRK

115.62

-2.51%↓

Inicio・Lista de Acciones・Inmode Ltd

Inmode Ltd

Cerrado

SectorSanidad

13.92 -0.93

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

13.88

Máximo

13.94

Métricas clave
By Trading Economics
Ingresos	-15M 12M
Ventas	-22M 82M
P/B Media del Sector	10.178 50.102
BPA	0.25
Margen de beneficios	14.097
Empleados	660
EBITDA	-21M 10M

Recomendaciones
By TipRanks
Recomendaciones	Neutral
Estimación a 12 Meses	+13.07% upside

Dividendos
By Dow Jones
Próximas Ganancias	29 jul 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-71M 836M
Apertura anterior	14.85
Cierre anterior	13.92

Noticias sobre sentimiento de mercado

By Acuity

50%

124 / 344 Clasificación en Healthcare

Inmode Ltd Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

31 may 2026, 23:44 UTC

Charlas de Mercado

Nikkei May Remain Rangebound Amid Middle East Uncertainty -- Market Talk

31 may 2026, 23:36 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

31 may 2026, 23:36 UTC

Charlas de Mercado

Oil Rises Amid Few Signs of Strait of Hormuz's Reopening -- Market Talk

31 may 2026, 23:36 UTC

Charlas de Mercado

Watch for Data-Center Investment in Australia's 1Q GDP Print -- Market Talk

31 may 2026, 22:54 UTC

Adquisiciones, fusiones, absorciones

Berkshire Hathaway to Buy Homebuilder Taylor Morrison for $6.8 Billion -- WSJ

29 may 2026, 23:08 UTC

Adquisiciones, fusiones, absorciones

Family Offices Bypass Private Equity and Go Direct -- Barrons.com

29 may 2026, 23:06 UTC

Adquisiciones, fusiones, absorciones

After a Series of Sales, Hims Director Buys Company Shares -- Barrons.com

29 may 2026, 20:53 UTC

Ganancias

Oil Declines Lift Stocks to Fresh Records -- WSJ

29 may 2026, 20:50 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

29 may 2026, 20:33 UTC

Charlas de Mercado

Canada Meets Only One of Three Criteria To Declare Recession -- Market Talk

29 may 2026, 20:11 UTC

Ganancias

Okta Stock Soars. What's Stealing the Show From Earnings. -- Barrons.com

29 may 2026, 19:47 UTC

Ganancias

These Were the Best and Worst S&P 500 Stocks in May -- Barrons.com

29 may 2026, 19:36 UTC

Charlas de Mercado

U.S. Natural Gas Futures End Month With Gains -- Market Talk

29 may 2026, 19:34 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

29 may 2026, 19:34 UTC

Charlas de Mercado

Over Half of Canadian Industries Growing, Undermining Recession Talk -- Market Talk

29 may 2026, 19:22 UTC

Charlas de Mercado

Oil Falls as U.S., Iran Expected to Reach Agreement -- Market Talk

29 may 2026, 19:05 UTC

Adquisiciones, fusiones, absorciones

Universal Music Group Rejects $65 Billion Takeover Bid From Bill Ackman's Pershing Square -- Barrons.com

29 may 2026, 18:19 UTC

Charlas de Mercado

Canada Technical Recession Chatter Rife But Per-Capita GDP Was Up -- Market Talk

29 may 2026, 18:12 UTC

Adquisiciones, fusiones, absorciones

Universal Music Group Rejects $65 Billion Buyout Offer From Bill Ackman -- WSJ

29 may 2026, 18:11 UTC

Charlas de Mercado

Canada Households Reaching Limit at Keeping Spending in Positive Territory -- Market Talk

29 may 2026, 18:10 UTC

Charlas de Mercado

As BTC Long-Term Holders Rise, Short-Term Holders Flee -- Market Talk

29 may 2026, 17:55 UTC

Ganancias

Okta Stock Soars. What's Stealing the Show From Earnings. -- Barrons.com

29 may 2026, 17:55 UTC

Charlas de Mercado

NEAR Protocol Nearly Doubles in May -- Market Talk

29 may 2026, 17:38 UTC

Charlas de Mercado

U.S. Oil Rig Count Rises for Fifth Straight Week -- Market Talk

29 may 2026, 17:00 UTC

Ganancias

Okta Stock Soars After Earnings. Results Aren't the Real Catalyst. -- Barrons.com

29 may 2026, 16:20 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

29 may 2026, 16:20 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

29 may 2026, 16:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

29 may 2026, 16:02 UTC

Charlas de Mercado

Gold Extend Gains as Investors Await U.S.-Iran Deal News -- Market Talk

29 may 2026, 15:55 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

Comparación entre iguales

Cambio de precio

Inmode Ltd previsión

Precio Objetivo

By TipRanks

13.07% repunte

Estimación a 12 Meses

Media 15.75 USD 13.07%

Máximo 19 USD

Mínimo 14 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Inmode Ltd Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

5 ratings

Comprar

Mantener

Vender

De acuerdo con 5 analistas que ofrecen calificaciones bursátiles a para Inmode Ltd Dist en los últimos 3 meses.

Sentimiento

By Acuity

124 / 344 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Inmode Ltd

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokne'am, Israel.